1Casati V, Guzzon D, Oppizzi M, et al. Tranexamic acid compared with high - dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allergenic transfusions. J Thorac Cardiovase Surg, 2000,120(3) :520 ～ 527
2Cosgrove DM Ⅲ, Heric B, Lyttle BW, et al. Aprotinin therapy for reoporativemyoeardial revaseularization: a plaeebocontrolled study. Ann Thorac Surg, 1992,54:1031 ～ 1038
3Donahue MA, Price PM. Aprotinin:antifibrinolytic and anti - inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.Dynamics, 2002,13(3): 16 ～ 23
4Landis RC, Asimakopoulos G,Poullis M, et al. The antithrombotie and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg, 2001 Dec; 72(6) :2169 ～ 2175
5Boldt J, Knothe C, Zickmannn B,Bill S, et al. Platelet function in cardic surgery: influence of temperature and aprotinin. Ann Thorac Surg, 1993,55:652 ～ 658
6Westaby S. Coagulation disturbances in profound hypothermia: the influence of anti - fibrinolytic therapy.Seminars in Thorac and Cardiovasc Surg, 1997, 9:246～256
7Reed RLII, Bracey AW, Hudson JD,et al. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.Circ Shock, 1990,32:141 ～ 152
8Ferroni P, Speziale G, Ruvolo G, et al. Platelet activation and cytokine production during hypothermia cardiopulmonary bypass - a possible correlation? Thromb Hacmost, 1998,80:58 ～ 64
9Komai H, Haworth SG. Effect of cardiopulmonary bypass on the circulating level of soluble GMP- 140. Ann Thorac Surg, 1994, 58:478 ～ 482
10Mazer CD, Homstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg, 1995,59: 1481～ 1486
